Immunogenicity studies with a genetically engineered hexavalent PorA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys

By Rouppe van der Voort E.   Schuller M.   Holst J.   de Vries P.   van der Ley P.   van den Dobbelsteen G.   Poolman J.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1334-1343

Elsevier

Access to resources Recommend Favorite

Engineered Listeria monocytogenes as an AIDS vaccine

By Lieberman J.   Frankel F.R.  

Vaccine, Vol. 20, Iss. 15, 2002-05 ,pp. : 2007-2010

Elsevier

Access to resources Recommend Favorite

Experimental quantification of transmission of genetically engineered pseudorabies virus

By Mulder W.A.M.   De Jong M.C.M.   Priem J.   Bouma A.   Pol J.M.A.   Kimman T.G.  

Vaccine, Vol. 13, Iss. 18, 1995-01 ,pp. : 1763-1769

Elsevier

Access to resources Recommend Favorite

Potency testing of a live, genetically attenuated vaccine for salmonids

By Marsden M.J.   Vaughan L.M.   Fitzpatrick R.M.   Foster T.J.   Secombes C.J.  

Vaccine, Vol. 16, Iss. 11, 1998-07 ,pp. : 1087-1094

Elsevier

Access to resources Recommend Favorite

A genetically-defined riboflavin auxotroph of Actinobacillus pleuropneumoniae as a live attenuated vaccine

By Fuller T.E.   Thacker B.J.   Duran C.O.   Mulks M.H.  

Vaccine, Vol. 18, Iss. 25, 2000-06 ,pp. : 2867-2877

Elsevier

Access to resources Recommend Favorite